The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Argentine President Fernandez on defensive over vaccine scandal, warns of more firings

Tue, 23rd Feb 2021 18:17

By Raul Cortes

MEXICO CITY, Feb 23 (Reuters) - Argentine President Alberto
Fernández was on the defensive on Tuesday over a "VIP" vaccine
scandal that has roiled the South American country, and said
more heads could roll if people were found to have used their
position to get inoculated.

The scandal has already led to the resignation of Health
Minister Ginés González García after some people close to the
government got early access to vaccines, putting pressure on
Fernandez's center-left government as it rolls out its vaccine
program.

"To your question of whether I am going to ask for more
resignations, look, if there are more responsible, those who
have to leave will have to go," Fernández said at a news
conference during a visit to Mexico.

Fernandez added that he had never endorsed the vaccination
of people connected to government, but criticized the fierce
response of his opponents and critics as "clowning."

Since the scandal emerged last week, the government has
posted a list of those inoculated, many of whom it said were
officials given vaccines due the needs of their functions. It
also included some family members of prominent politicians.

Argentina's new health minister Carla Vizzotti has pledged
greater transparency over vaccines, while the Attorney for
Administrative Investigations has opened a file to look into
whether there were any abuses of power.

The country's Cabinet chief Santiago Cafiero on Twitter
defended the president and said he had "acted quickly" on the
matter. "He disapproved of what was done wrong and corrected it
to make the vaccination plan transparent," he said.

With a population of about 45 million, Argentina has so far
received 1.22 million doses of the Sputnik V vaccine from the
Russian Gamaleya Institute and 580,000 doses of the Covishield
vaccine, developed by the University of Oxford and AstraZeneca
and manufactured by the Indian Serum Institute.
(Reporting by Raúl Cortés in Mexico City; Editing by Adam
Jourdan and Bill Berkrot)

Related Shares

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.